Iovance Biotherapeutics Inc (IOVA)
Healthcare
Biotechnology
4.10 $
-13.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Iovance Biotherapeutics Inc (IOVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -72 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -94 | -84 | -84 | -122 | -98 | -59 | -73 | -104 | -67 | -79 | -53 | -72 | -271 | |
| 7.8 | 9.9 | 9.7 | 9.9 | 11 | 11 | 12 | 11 | 12 | 12 | 18 | 7.6 | 49 | |
| 17 | 16 | 14 | 17 | 30 | 31 | 31 | 23 | 15 | 12 | 12 | 11 | 50 | |
| 16 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -11 | 5.9 | 12 | -33 | -39 | -13 | -38 | -18 | 9.2 | -8.5 | -7.3 | -13 | -20 | |
| 9.5 | 3.6 | 3.5 | 4.2 | 0.4 | 2.3 | 4.2 | 6.2 | 7.5 | 11 | 9.3 | 6.6 | 34 | |
| -157 | -79 | -73 | -112 | 40 | -49 | 24 | 16 | 14 | 17 | 0.8 | 11 | 43 | |
| -0.3 | -0.4 | -0.2 | -4.7 | -1.0 | 7.3 | – | – | – | 0.7 | 0.2 | – | – | |
| 1.0 | 203 | 1.0 | 194 | 153 | 42 | 2.3 | 143 | 13 | 88 | 56 | 94 | 252 | |
| -253 | 38 | -153 | -41 | 94 | -65 | -48 | 56 | -40 | 26 | 5.0 | -157 | -166 | |
| -103 | -88 | -87 | -126 | -99 | -61 | -77 | -110 | -75 | -90 | -62 | -79 | -305 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.